These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 25803536)

  • 1. [Beta lactam antibiotics and the question of dose regimen for severe infection. Prolonged infusion theoretically appealing--yet no evidence of clinical benefit].
    Leander G; Eliasson E; Hanberger H; Giske C
    Lakartidningen; 2015 Mar; 112():. PubMed ID: 25803536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subtleties in practical application of prolonged infusion of β-lactam antibiotics.
    De Waele JJ; Lipman J; Carlier M; Roberts JA
    Int J Antimicrob Agents; 2015 May; 45(5):461-3. PubMed ID: 25749200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous versus Intermittent β-Lactam Infusion in Severe Sepsis. A Meta-analysis of Individual Patient Data from Randomized Trials.
    Roberts JA; Abdul-Aziz MH; Davis JS; Dulhunty JM; Cotta MO; Myburgh J; Bellomo R; Lipman J
    Am J Respir Crit Care Med; 2016 Sep; 194(6):681-91. PubMed ID: 26974879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A protocol for a multicentre randomised controlled trial of continuous beta-lactam infusion compared with intermittent beta-lactam dosing in critically ill patients with severe sepsis: the BLING II study.
    Dulhunty JM; Roberts JA; Davis JS; Webb SA; Bellomo R; Gomersall C; Shirwadkar C; Eastwood GM; Myburgh J; Paterson DL; Starr T; Udy AA; Paul SK; Lipman J; ;
    Crit Care Resusc; 2013 Sep; 15(3):179-85. PubMed ID: 23944203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benefits of prolonged infusion of beta-lactam antibiotics in patients with sepsis: personal perspectives.
    Rafailidis PI; Falagas ME
    Expert Rev Anti Infect Ther; 2020 Oct; 18(10):957-966. PubMed ID: 32564641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-Lactam Infusion in Severe Sepsis (BLISS): a prospective, two-centre, open-labelled randomised controlled trial of continuous versus intermittent beta-lactam infusion in critically ill patients with severe sepsis.
    Abdul-Aziz MH; Sulaiman H; Mat-Nor MB; Rai V; Wong KK; Hasan MS; Abd Rahman AN; Jamal JA; Wallis SC; Lipman J; Staatz CE; Roberts JA
    Intensive Care Med; 2016 Oct; 42(10):1535-1545. PubMed ID: 26754759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A protocol for a phase 3 multicentre randomised controlled trial of continuous versus intermittent β-lactam antibiotic infusion in critically ill patients with sepsis: BLING III.
    Lipman J; Brett SJ; De Waele JJ; Cotta MO; Davis JS; Finfer S; Glass P; Knowles S; McGuinness S; Myburgh J; Paterson DL; Peake S; Rajbhandari D; Rhodes A; Roberts JA; Shirwadkar C; Starr T; Taylor C; Billot L; Dulhunty JM
    Crit Care Resusc; 2019 Mar; 21(1):63-68. PubMed ID: 30857514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged versus short-term intravenous infusion of antipseudomonal β-lactams for patients with sepsis: a systematic review and meta-analysis of randomised trials.
    Vardakas KZ; Voulgaris GL; Maliaros A; Samonis G; Falagas ME
    Lancet Infect Dis; 2018 Jan; 18(1):108-120. PubMed ID: 29102324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous infusion of beta-lactam antibiotics in severe infections: a review of its role.
    Roberts JA; Paratz J; Paratz E; Krueger WA; Lipman J
    Int J Antimicrob Agents; 2007 Jul; 30(1):11-8. PubMed ID: 17442541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous infusion of beta-lactam antibiotics to treat severe sepsis: a waste of time or worth the hassle?
    Dunning J; Roberts J
    Br J Hosp Med (Lond); 2015 May; 76(5):310. PubMed ID: 25959950
    [No Abstract]   [Full Text] [Related]  

  • 11. Continuous infusion of beta-lactam antibiotics in severe sepsis: a multicenter double-blind, randomized controlled trial.
    Dulhunty JM; Roberts JA; Davis JS; Webb SA; Bellomo R; Gomersall C; Shirwadkar C; Eastwood GM; Myburgh J; Paterson DL; Lipman J
    Clin Infect Dis; 2013 Jan; 56(2):236-44. PubMed ID: 23074313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolonged administration of β-lactam antibiotics - a comprehensive review and critical appraisal.
    Osthoff M; Siegemund M; Balestra G; Abdul-Aziz MH; Roberts JA
    Swiss Med Wkly; 2016; 146():w14368. PubMed ID: 27731492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detailed regimens for the prolonged β-lactam infusion therapy.
    Hagiya H
    J Infect Chemother; 2024 Dec; 30(12):1324-1326. PubMed ID: 38977073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In sepsis or septic shock, prolonged vs. intermittent infusion of β-lactam antibiotics reduces mortality at 90 d.
    Walker MK; Strich JR
    Ann Intern Med; 2024 Sep; 177(9):JC103. PubMed ID: 39222508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between augmented renal clearance, antibiotic exposure and clinical outcome in critically ill septic patients receiving high doses of β-lactams administered by continuous infusion: a prospective observational study.
    Carrié C; Petit L; d'Houdain N; Sauvage N; Cottenceau V; Lafitte M; Foumenteze C; Hisz Q; Menu D; Legeron R; Breilh D; Sztark F
    Int J Antimicrob Agents; 2018 Mar; 51(3):443-449. PubMed ID: 29180280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonging β-lactam infusion: a review of the rationale and evidence, and guidance for implementation.
    MacVane SH; Kuti JL; Nicolau DP
    Int J Antimicrob Agents; 2014 Feb; 43(2):105-13. PubMed ID: 24359838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Multicenter Randomized Trial of Continuous versus Intermittent β-Lactam Infusion in Severe Sepsis.
    Dulhunty JM; Roberts JA; Davis JS; Webb SA; Bellomo R; Gomersall C; Shirwadkar C; Eastwood GM; Myburgh J; Paterson DL; Starr T; Paul SK; Lipman J;
    Am J Respir Crit Care Med; 2015 Dec; 192(11):1298-305. PubMed ID: 26200166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged vs Intermittent Infusions of β-Lactam Antibiotics in Adults With Sepsis or Septic Shock: A Systematic Review and Meta-Analysis.
    Abdul-Aziz MH; Hammond NE; Brett SJ; Cotta MO; De Waele JJ; Devaux A; Di Tanna GL; Dulhunty JM; Elkady H; Eriksson L; Hasan MS; Khan AB; Lipman J; Liu X; Monti G; Myburgh J; Novy E; Omar S; Rajbhandari D; Roger C; Sjövall F; Zaghi I; Zangrillo A; Delaney A; Roberts JA
    JAMA; 2024 Aug; 332(8):638-648. PubMed ID: 38864162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Revisiting Beta-lactams - PK/PD improves dosing of old antibiotics.
    MacGowan A
    Curr Opin Pharmacol; 2011 Oct; 11(5):470-6. PubMed ID: 21862409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous infusion vs. bolus dosing: implications for beta-lactam antibiotics.
    Mohd Hafiz AA; Staatz CE; Kirkpatrick CM; Lipman J; Roberts JA
    Minerva Anestesiol; 2012 Jan; 78(1):94-104. PubMed ID: 21730935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.